Summit Therapeutics
#1192
Rank
$15.85B
Marketcap
United Kingdom
Country
Mr. Robert W. Duggan (CEO & Exec. Chairman)
Dr. Mahkam Zanganeh D.D.S., M.B.A., MBA (Co-CEO, Pres & Director)
Dr. Urte Gayko Ph.D. (Head of Regulatory Affairs, Quality Assurance & Safety and Director)
Summary
History
Summit Therapeutics was founded in 2003 and is based in Oxford, United Kingdom. The company has multiple subsidiaries worldwide, including those in the US, Europe, and Canada. The company's focus is on discovering, developing, and ultimately commercialising small molecule medicines for the treatment of infectious diseases and other conditions with unmet needs. The company’s lead product is ridinilazole, which is in clinical development to treat Clostridioides difficile infection.
Mission
Vision
Key Team
Mr. Campbell Hair (Head of HR?)
Prof. Dame Kay Davies DBE, FRS CBE (Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor)
Mr. Ankur Dhingra (Chief Financial Officer)
Ms. Michelle Avery (Director of Investor Relations)
Dr. Elaine Carla Stracker J.D., Ph.D. (Head of Compliance? & Gen. Counsel)
Dr. Anne Heatherington (Head of Clinical Devel. and Quantitative Sciences)
Ms. Divya Chari (Head of Global Clinical Operations)
Recognition and Awards
References
Mr. Robert W. Duggan (CEO & Exec. Chairman)
Dr. Mahkam Zanganeh D.D.S., M.B.A., MBA (Co-CEO, Pres & Director)
Dr. Urte Gayko Ph.D. (Head of Regulatory Affairs, Quality Assurance & Safety and Director)